EP3377041
Aðferð til uppdeilingar og/eða til að miða lyfjafræðilega virkum efnisþáttum á liðslímuvef
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.11.2016EP published:
25.10.2023EP application number:
16822736.1
EP translation filed:
27.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
15.11.2036Expiry date:
15.11.2026Next due date:
30.11.2026
Title in English:
A METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUELanguage of the patent:
English
Timeline
Today
16.11.2016EP application
25.10.2023EP Publication
27.11.2023Translation submitted
15.12.2023Registration published
15.11.2026Expires
Owner
Name:
MedinCell S.A.Address:
3 rue des frères Lumière, 34830 Jacou, FR
Inventor
Name:
GAUDRIAULT, GeorgesAddress:
34080 Montpellier, FR
Name:
GRIZOT, SylvestreAddress:
34170 Castelnau le Lez, FR
Name:
HURTIG, MarkAddress:
East Garafraxa, Ontario L9W 7A5, CA
Name:
SHIVE, MatthewAddress:
Denver, Colorado 80220, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562255778 PDate:
16.11.2015Country:
US
Classification
Categories:
A61K 9/08, A61P 3/02, A61K 31/12, A61K 31/165, A61K 31/167, A61K 31/18, A61K 31/192, A61K 31/196, A61K 31/365, A61K 31/4152, A61K 31/42, A61K 31/444, A61K 31/445, A61K 31/5415, A61K 31/621
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 29.11.2023
Expires: 15.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 25.11.2024
Expires: 15.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 24.11.2025
Expires: 15.11.2026
Payer: Árnason Faktor ehf.